CCL5 and breast cancer: In addition, bone marrow‐derived CCL5 could promote the growth of triple negative breast cancer by regulating the production of myeloid‐derived suppressor cells (MDSCs),37 which indicated that it may indirectly promote the growth of breast cancer by influencing the recruitment of tumor‐related immune cells.